Promoter substitution for immunoglobin therapy

Promoter substitution for immunoglobin therapy

Provided by: Oklahoma Medical Research Foundation (OMRF)
Tags: anti-cancer cancer Breast Cancer GPCR Cell Line
Short Description:

This technology pertains to immunoglobin (Ig) promoters, in particular murine Ig promoters, to function differentially.

Projects based on this Technology

Start New Project